Delays in treating a patient with an aggressive form of prostate cancer more than likely contributed to his disease advancing ...
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman ...
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...
Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
THOMASVILLE — Archbold Urology is committed to offering patients in the region access to the most advanced treatments for ...
Clinically known as benign prostatic hyperplasia (BPH), enlarged prostate is a non‑cancerous condition that affects roughly ...
Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper ...
I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive ...
I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive ...
PORTLAND, Ore. (KOIN) — The Oregon Legislature passed a new bill to eliminate barriers that prevent people from getting vital screening for cervical cancer and care. Senate Bill 1527 prohibits ...